The effect of aspartate and glutamate on myocardial function during reperfusion is controversial. A beneficial effect has been attributed to altered delivery of carbon into the citric acid cycle via substrate oxidation or by stimulation of anaplerosis, but these hypotheses have not been directly tested. "C isotopomer analysis is well suited to the study of myocardial metabolism, particularly where isotopic and metabolic steady state cannot be established. This technique was used to evaluate the effects of aspartate and glutamate (amino acids, AA) on anaplerosis and substrate selection in the isolated rat heart after 25 min of ischemia followed by 30 or 45 min of reperfusion. Five groups of hearts (n = 8) provided with a mixture of 11,2-'3Clacetate, 13-13Cllactate, and unlabeled glucose were studied: control, control plus AA, ischemia followed by 30 min of reperfusion, ischemia plus AA followed by 30 min of reperfusion, and ischemia followed by 45 min of reperfusion. The contribution of lactate to acetyl-CoA was decreased in postischemic myocardium (with a significant increase in acetate), and anaplerosis was stimulated. Metabolism of 13C-labeled aspartate or glutamate could not be detected, however, and there was no effect of AA on functional recovery, substrate selection, or anaplerosis. Thus, in contrast to earlier reports, aspartate and glutamate have no effect on either functional recovery from ischemia or on metabolic pathways feeding the citric acid cycle. (J. Clin. Invest. 1993. 92:831-839.)
Introduction
The activities of the metabolic pathways feeding the citric acid cycle are disrupted during ischemia and reperfusion (1) (2) (3) (4) (5) (6) . An understanding of the quantitative extent of these alterations is important for both diagnosis and therapy in reperfused myocardium. For example, clearance of "C-enriched acetate may be monitored in patients by positron tomography (7) (8) (9) , yet the biochemical basis of altered tracer clearance during ischemia is incompletely understood (10) (11) (12) . Of perhaps greater significance is the potential for improving recovery after ischemia by deliberately modifying carbon flow into the citric acid cycle. For example, a protective effect of aspartate and glutamate in models of myocardial ischemia is widely recognized (13) (14) (15) (16) (17) and application in clinical trials is underway ( 1 8, 19) . Under normal conditions, amino acids contribute little to acetyl-CoA, but, in post-ischemic myocardium, aspartate and glutamate may indirectly alter substrate selection by stimulating both pyruvate transamination and glycolysis (20) . Any shift from fatty acids to carbohydrates would be beneficial because ofoxygen sparing, which has been documented in animal models (21) (22) (23) and supported by clinical observations (24) (25) (26) (27) .
Another potentially beneficial intervention is stimulation of pathways that replenish citric acid cycle intermediates. These pathways, termed anaplerosis by Kornberg (28) , are active in the heart during ischemia (29) , and stimulation with propionyl-carnitine improves recovery of ischemic myocardium (30) . Aspartate and glutamate may enter the citric acid cycle via transamination and increase the concentration of citric acid cycle intermediates ( 15) . Activation of these pathways may be beneficial by increasing net flux through the citric acid cycle or by increasing high energy phosphates via substratelevel phosphorylation ( 31 ) .
Although substrate selection in reperfused myocardium has been studied extensively, information concerning anaplerotic activity is not available. Substrate selection is usually determined by measurements of arteriovenous differences or "CO2 release from '4C-enriched compounds, and measurement of anaplerosis typically involves purification and carbon-by-carbon degradation of intermediates (32) . Both measurements are difficult in reperfused myocardium where isotopic and metabolic steady state are difficult to establish. '3C is a stable isotope that has recently been applied to numerous problems in intermediary metabolism (33) (34) (35) . '3C isotopomer analysis offers advantages over other measurements of substrate selection because it is technically simple, and anaplerosis and competition among several substrates can be assessed in a single experiment (36) (37) (38) . Further, requirement for steady state conditions does not apply to measurements of substrate selection (39, 40) .
For these reasons 'C-nuclear magnetic resonance (NMR) spectroscopy was used to address two questions: what are the (40) . The metabolic effects of these amino acids are of longstanding interest, and plausible biochemical mechanisms that are consistent with their beneficial effects have been suggested but not tested. Lactate was examined because its utilization is avid in normoxic myocardium (41 ) but is suppressed during severe ischemia because of inhibition of the pyruvate dehydrogenase complex (42) . Acetate was studied because it provides an alternative carbon source, which bypasses pyruvate dehydrogenase, and because of its importance as a tracer for positron tomography studies.
Methods
Materials. The following '3C-enriched compounds were used: [3- Dawley rats weighing 300-400 g with free access to food and water were used in these investigations and were cared for in the Animal Resources Center (43). Animals were anesthetized with 4% chloral hydrate ( 1 ml/ 100 g, i.p.), and heparin ( 100 U/ 100 g) was administered via the femoral vein. The heart was excised, and the aorta was cannulated for retrograde (Langendorff) perfusion. Hearts were perfused at 100 cm of water throughout the experiment except during the ischemic periods. Typical coronary flow was 15-18 ml/min, and the perfusate was not recirculated. The heart chamber was immersed in a controlled-temperature bath maintained at 37°C. A latex balloon was inserted into the left atrium across the mitral valve into the left ventricle. This balloon was connected via tubing to a pressure transducer, and pressure and dP/dT were recorded continuously. Pacing electrodes were attached to the right atrium and all hearts were paced at 300 beats per min at twice the diastolic threshold. Hearts that had an intrinsic rate > 300 beats per min were not paced. For inclusion in this study, rat hearts were required to achieve a left ventricular (LV) peak pressure of 90 mmHg at an end-diastolic pressure of < 10 mmHg by the end of the 20-min stability period. About 20% of hearts failed these criteria.
Coronary flow and functional data were recorded at the end of the stability period, at the end ofthe 25-min period for hearts not rendered ischemic, and at 1 5-min intervals during the reperfusion period. Developed pressure was calculated as the difference between LV peak and end-diastolic pressures. Heart rate was 300 beats per min for paced hearts and varied between 300 and 360 beats per min in nonpaced hearts. Rate-pressure product was calculated as the product of developed pressure and heart rate.
Perfusate composition. The perfusate used for these experiments was a modified Krebs-Henseleit solution bubbled with 95% 02/5% CO2. For experiments done without amino acids, the perfusate contained the following (mM): 118.0 NaCl, 4 Experimental protocol. The experimental protocol is shown in Fig.  1 for five groups ofeight animals. In group 1 (ischemia) rat hearts were perfused for a stabilization period of 20 min, and then made ischemic for 25 min by clamping the aortic cannula. After completion of the ischemic period, hearts were reperfused for 30 min using the solution containing the '3C-enriched substrates and freeze-clamped. Group 2 (control) hearts were stabilized for 20 min and then perfused for an additional 25-min interval. The perfusing solution was then switched to one containing the '3C-labeled substrates and after an additional 30 min the hearts were freeze-clamped.
Group 3 (ischemia plus amino acids) followed an identical protocol to group 1 with the exception that the perfusing solutions contained 5 mM glutamate and 5 mM aspartate. Group 4 (control plus amino acids) followed an identical pattern to group 2 with the exception that the perfusating solutions contained glutamate and aspartate. The protocol for group 5 was identical to group 1 except that the hearts were reperfused for 45 min with labeled substrates.
Tissue extraction and '3C-NMR spectroscopy. Hearts were freezeclamped with aluminum tongs chilled in liquid nitrogen, extracted with cold perchloric acid, neutralized with KOH, freeze-dried, and dissolved in 0.5 ml of D20 for NMR analysis (36) . Proton decoupled 13C spectra were obtained at 100.3 MHz on a spectrometer (Omega; General Electric Co., Wilmington, MA). Spectra of heart extracts were acquired in a 5-mm tube using a 450 carbon pulse, 16 K data points over 22,000-26,000 Hz, and a 6-s delay between pulses. Protons were decoupled using the WALTZ sequence at two power levels (BILEV), and the temperature was maintained at 25°C using a standard variable temperature accessory (General Electric Co.). All spectra were zerofilled to 32 K points before Fourier transformation. The relative areas of the multiplet components in each glutamate resonance were determined using commercial software (NMR-1; New Methods Research, Inc., Syracuse, NY). Fig. 2 , competition between these substrates may be appreciated by simple inspection of the C4 resonance (40) .
The glutamate spectrum was quantitatively analyzed using the nonsteady state (37, 39) and steady state (36) (37) (38) (39) Table I .
A typical '3C-NMR spectrum from a control heart (group 2) is shown in Fig. 3 hearts (groups 2 and 4). In all cases, the source of anaplerosis appeared to arise mainly (-80%) from unlabeled carbon sources.
Effect of aspartate and glutamate on ventricular performance and metabolism. Aspartate and glutamate had no effect on myocardial function in normoxic hearts (Table I) 1 vs. 3) . Also, anaplerotic flux was low in normoxic hearts and was not altered by aspartate and glutamate (Table IV) . Reperfusion after 25 min of ischemia increased anaplerosis relative to citric acid cycle flux (Table IV) gether, these observations confirm that neither aspartate nor glutamate are metabolized in the citric acid cycle under these conditions. Correlation between functional recovery and metabolic state. To examine the relationship between myocardial performance and metabolic state, data from all 40 hearts were combined. A strong correlation was observed between cardiac function and pathways feeding the citric acid cycle (Fig. 6 ). There was a positive correlation between lactate utilization and ratepressure product (r = 0.92, Fig. 6 A) . A similar correlation was observed between the ratio of lactate to acetate utilization and ventricular function (r = 0.91, Fig. 6 B) . A negative correlation was found between anaplerosis and function (r = -0.90, Fig. 6  C) . Thus, higher levels of anaplerosis relative to citric acid cycle flux were associated with impaired ventricular performance. These relations remained statistically significant when only postischemic hearts were analyzed. 
Discussion
This model of prolonged global normothermic ischemia and reperfusion was chosen to allow comparison to numerous previous investigations (14, 16, 17, 20, 31, 46) . '3C-NMR was used to test previous hypotheses regarding the effects of amino acids on substrate selection, anaplerosis, and functional recovery after ischemia. The protective effects of glutamate and aspartate on ischemic heart tissue were not confirmed in this study. Other investigators have observed improvements in postischemic cardiac performance when the perfusate is enriched with these amino acids. Exposure to 2 mM glutamate before, during, and after severe ischemia leads to improved functional recovery in the intact rabbit heart ( 16). Glutamate at higher concentrations (20 mM) during underperfusion of isolated rat hearts greatly reduced the resulting contractile dysfunction ( 14) . Addition of C2, C3, and C4 refer to the carbon resonances observed in the proton-decoupled '3C-NMR spectrum of glutamate (37, 39) . Each resonance is composed of multiplets which are denoted as S, singlet, D, doublet (with carbon-carbon coupling); T, triplet; and Q, quartet, or doublet of doublets. Examples of "3C spectra are shown in Fig. 4 , and other abbreviations are in Table I . Results are mean±SD (n = 8).
aspartate and glutamate to cardioplegic solutions during ( 17) or after (47) ischemia also has been associated with superior recovery of function during the reperfusion period.
It is difficult to attribute the lack of functional benefit of aspartate and glutamate found in this study to major differences in the experimental model compared with earlier studies. The concentrations of amino acids used in the present study were higher than those found effective in some earlier reports ( 16) . In our study, amino acids were provided both before and after ischemia to increase the chance of showing an effect. The severity of the ischemic episode may have been too great, although beneficial effects have been observed with longer periods of low flow ischemia ( 14, 31 ). Similar to our results, Galinanes et al. (46) could not detect a protective effect independent of changes in perfusate sodium caused by addition of sodium aspartate. Nevertheless, the effects ofthese amino acids may be highly dependent on the experimental protocol, and a salutary effect ofexogenous amino acids may certainly be present under other conditions.
The functional benefits described earlier have been attributed to several mechanisms. One suggestion is that glutamate may alter myocardial substrate utilization. Thomassen and coworkers (48) demonstrated a change in substrate preference from free fatty acid use toward glucose and glutamate consumption in patients receiving an infusion of glutamate. Pacing-induced myocardial lactate release was reduced after glutamate administration in patients with ischemic heart disease, and pacing tolerance, an indirect indication ofischemic threshold, was improved (49) . We found no alteration in substrate selection upon addition of 5 mM aspartate and glutamate in control hearts or in hearts recovering from a 25-min ischemic episode.
Another potential protective mechanism for these amino acids could involve their entry into the citric acid cycle intermediate pools via transamination ofglutamate and pyruvate to yield a-ketoglutarate plus alanine or between aspartate and pyruvate to yield oxaloacetate plus alanine. During ischemia the concentration ofalanine increases (29) and the concentrations of glutamate and aspartate decrease, perhaps indicating that the myocardium is capable of transamination via these pathways. Addition of exogenous glutamate could theoretically increase a-ketoglutarate levels ( 16) , which could then generate high energy phosphates via substrate level phosphorylation ( 14) in subsequent reactions. However, succinyl-CoA generation from a-ketoglutarate requires NAD+, which is depleted during ischemia. Some authors have suggested that oxaloacetate derived from aspartate may oxidize NADH via reversal of malate dehydrogenase and therefore support a greater role for aspartate than glutamate in ischemic protection ( 17) . Furthermore, others have demonstrated a direct inhibitory effect of glutamate on pyruvate carboxylase (50) in other tissues, which is thought to be a major anaplerotic mechanism in the heart ( 51 ) .
Despite the absence of functional benefits, the metabolic changes suggested by others should have been readily detected in the present study because '3C-NMR is sensitive to the activity of pathways feeding acetyl-CoA and entry of either labeled or unlabeled molecules into the citric acid cycle pools via an analysis. Finally, anaplerosis measured at either 30 or 45 min was substantially higher than control conditions. The study is consistent with earlier work that found suppression oflactate relative to fatty acid ( 1 ) or acetate (40) utilization early during reperfusion. This effect has been attributed to suppression of pyruvate dehydrogenase activity during ischemia which effectively reduces carbohydrate contributions to acetyl-CoA. These data demonstrate a significant correlation between functional recovery after ischemia and substrate selection by the myocardium. Such information may prove useful in evaluating myocardial viability or in formulating strategies to improve cardiac performance after ischemia.
This study also illustrates the simplicity of analysis of substrate selection by a single '3C-NMR spectrum. Competition among two labeled substrates and unlabeled materials could be assessed in a single experiment without assuming metabolic or isotopic steady state. This method is generally useful in analysis of substrate selection during reperfusion where substrate selection is controversial.
